LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 1, 2008, Pages 183-193

  de Castro, A ^a   Concheiro, M ^a   Quintela, O ^a   Cruz, A ^a   Lopez Rivadulla M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Antidepressant; LC MS MS; Oral fluid; Plasma; Venlafaxine

Indexed keywords

ACETONITRILE; AMITRIPTYLINE; AMMONIUM FORMATE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; NORCLOMIPRAMINE; NORFLUOXETINE; NORTRIPTYLINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; DRUG SALIVA LEVEL; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ANTIDEPRESSIVE AGENTS; CHROMATOGRAPHY, LIQUID; CYCLOHEXANOLS; FEMALE; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SALIVA; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 49749113235     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.05.024     Document Type: Article

References (47)

1. Schartzberg A.F. Hum. Psychopharmacol. 17 (2002) 17S-22S
2. Whyte I.M., Dawson A.H., and Buckley N.A. Q. J. Med. 96 (2003) 369-374
3. Buckley N.A., and McManus P.R. Br. Med. J. 325 (2002) 1332-1333
4. Pacher P., Ungvari Z., Nanasi P.P., Furst S., and Kecskemeti V. Curr. Med. Chem. 6 (1999) 469-480
5. Anderson I.M. J. Affect. Disord. 58 (2000) 19-36
6. Rochat B., Amey M., and Baumann P. Ther. Drug Monit. 17 (1995) 273-279
7. Ereshefsky L., and Dugan D. Depress. Anxiety 12 (2000) 30-44
8. Burke M.J., and Preskorn S.H. Clin. Pharmacokinet. 37 (1999) 147-165
9. Lundmark J., Bengtsson F., Nordin C., Reis M., and Wålinder J. Acta Psychiatr. Scand. 101 (2000) 354-359
10. Mann K., Hiemke C., Schmidt L.G., and Bates D.W. Ther. Drug Monit. 28 (2006) 83-88
11. Rasmussen B.B., and Brøsen K. Ther. Drug Monit. 22 (2000) 143-154
12. Orsulak P., and Schildkraut J.J. Ther. Drug Monit. 1 (1979) 199-208
13. Mitchell P.B. Br. J. Clin. Pharmacol. 52 (2001) 45S-54S
14. Mitchell P.B. Clin. Chem. Lab. Med. 42 (2004) 1212-1218
15. Horning M.G., Brown L., Nowlin J., Lertratanangkoon K., Kellaway P., and Zion T.E. Clin. Chem. 23 (1977) 157-164
16. Coates J.E., Lam S.F., and McGaw W.T. Clin. Chem. 34 (1988) 1545-1551
17. Jenkins A.J., Henningfield J.E., and Cone E.J. Ther. Drug. Monit. 27 (2005) 345-348
18. Liu H., and Delgado M.R. Clin. Pharmacokinet. 36 (1999) 453-470
19. Flarakos J., Luo W., Aman M., Svinarov D., Gerber N., and Vouros P. J. Chromatogr. A 1026 (2004) 175-183
20. Eerkes A., Weng N., King M., Du A., and Shou W.Z. J. Liquid Chromatogr. Related Technol. 25 (2002) 1215-1227
21. Li C., Ji Z., Nan F., Shao Q., Liu P., Dai J., Zhen J., Yuan H., Xu F., Cui J., Huang B., Zhang M., and Yu C. Rapid Commun. Mass Spectrom. 16 (2002) 1844-1850
22. Souverain S., Mottaz M., Cherkaoui S., and Veuthey J.L. Anal. Bioanal. Chem. 377 (2003) 880-885
23. Zhu Z., and Neirinck L. J. Chromatogr. B 780 (2002) 295-300
24. Jain D.S., Sanyal M., Subbaiah G., Pande U.C., and Shrivastav P. J. Chromatogr. B 829 (2005) 69-74
25. Kristoffersen I., Bugge A., Lundanes E., and Slørdal L. J. Chromatogr. B 734 (1999) 229-246
26. Juan H., Zhiling Z., and Huande L. J. Chromatogr. B 820 (2005) 33-39
27. Kollroser M., and Schober C. Chromatographia 57 (2003) 133-138
28. Kollroser M., and Schober C. Ther. Drug Monit. 24 (2002) 537-544
29. Goeringer K.E., McIntyre I.M., and Drummer O. J. Anal. Toxicol. 27 (2003) 30-35
30. Shinozuka T., Terada M., and Tanaka E. Forensic Sci. Int. 162 (2006) 108-112
31. Kirchherr H., and Kühn-Velten W.N. J. Chromatogr. B 843 (2006) 100-113
32. Sauvage F.L., Gaulier J.M., Lachâtre G., and Marquet P. Ther. Drug Monit. 28 (2006) 123-130
33. de Castro A., Laloup M., Ramírez M.M., Wood M., Maes V., De Boeck G., and Samyn N. J. Chromatogr. A 1160 (2007) 3-12
34. Pujadas M., Pichini S., Civil E., Santamariña E., Perez K., and de la Torre R. J. Pharm. Biomed. Anal. 44 (2007) 594-601
35. Wylie F.M., Torrance H., Anderson R.A., and Oliver J.S. Forensic Sci. Int. 150 (2005) 191-198
36. Hartmann C., Smeyers-Verbeke J., Massart D.L., and McDowall R.D. J. Pharm. Biomed. Anal. 17 (1998) 193-218
37. Peters T., and Maurer H.H. Accred. Qual. Assur. 7 (2002) 441-449
38. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Millar K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551-1557
39. Peters F.T., Drummer O.H., and Musshoff F. Forensic Sci. Int. 165 (2007) 216-224
40. Dadgar D., Burnett P.E., Choc M.G., Gallicano K., and Hooper J.W. J. Pharm. Biomed. Anal. 13 (1995) 89-97
41. Annesley T.M. Clin. Chem. 49 (2003) 1041-1044
42. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 75 (2003) 3019-3030
43. Concheiro M., de Castro A., Quintela O., Cruz A., and López-Rivadulla M. J. Anal. Toxicol. 31 (2007) 573-580
44. Gross A.S. Best practice in therapeutic drug monitoring. Br. J. Clin. Pharmacol. 46 (1998) 95-99
45. Langman L.J. Ann. N. Y. Acad. Sci. 1098 (2007) 145-166
46. Drummer O.H. Forensic Sci. Int. 150 (2005) 133-142
47. Navarro M., Pichini S., Farré M., Ortuño J., Roset P.N., Segura J., and de la Torre R. Clin. Chem. 47 (2001) 1788-1795